Ethico Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -21.85%
(FY 2023)
- Profit -14.18%
(FY 2023)
- Ebitda 90.45%
(FY 2023)
- Net Worth 17.22%
(FY 2023)
- Total Assets -17.46%
(FY 2023)
About Ethico Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Gagan Bansal, Shubham Bansal, and Satyam Bansal serve as directors at the Company.
- CIN/LLPIN
U24230DL2009PTC197422
- Company No.
197422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2009
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ethico Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyam Bansal  | Director | 19-May-2020 | Current |
| Gagan Bansal | Director | 17-Jun-2015 | Current |
| Shubham Bansal | Director | 27-Jul-2019 | Current |
Financial Performance of Ethico Pharma.
Ethico Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.85% decrease. The company also saw a substantial fall in profitability, with a 14.18% decrease in profit. The company's net worth Soared by an impressive increase of 17.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ethico Pharma?
In 2023, Ethico Pharma had a promoter holding of 8.33% and a public holding of 91.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sun Bioceuticals Private LimitedActive 15 years 5 months
Gagan Bansal and Satyam Bansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ethico Pharma?
Unlock and access historical data on people associated with Ethico Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ethico Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ethico Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
